Sirtex Medical Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
53,771.00
75,154.00
108,712.00
118,349.00
127,896.00
Total Accounts Receivable
26,268.00
35,000.00
42,272.00
36,976.00
52,746.00
Inventories
1,678.00
1,836.00
1,918.00
1,993.00
2,781.00
Other Current Assets
2,024.00
3,210.00
4,212.00
5,158.00
6,178.00
Total Current Assets
83,741.00
115,200.00
157,114.00
162,476.00
189,601.00
Net Property, Plant & Equipment
13,592.00
13,164.00
13,987.00
12,045.00
10,642.00
Intangible Assets
47,364.00
68,027.00
82,821.00
9,436.00
8,258.00
Other Assets
-
-
-
-
1,362.00
Total Assets
148,710.00
201,476.00
261,717.00
194,122.00
225,544.00
Accounts Payable
7,649.00
13,638.00
16,296.00
13,550.00
12,968.00
Income Tax Payable
-
4,746.00
7,239.00
8,412.00
17,831.00
Other Current Liabilities
17,066.00
17,318.00
18,803.00
20,855.00
34,246.00
Total Current Liabilities
24,715.00
35,702.00
42,338.00
42,817.00
65,045.00
Provision for Risks & Charges
874.00
1,104.00
1,153.00
919.00
1,084.00
Deferred Taxes
11,525.00
14,949.00
16,927.00
9,246.00
15,443.00
Total Liabilities
41,127.00
56,840.00
68,213.00
44,655.00
66,367.00
Common Equity (Total)
107,583.00
144,636.00
193,504.00
149,467.00
159,177.00
Total Shareholders' Equity
107,583.00
144,636.00
193,504.00
149,467.00
159,177.00
Total Equity
107,583.00
144,636.00
193,504.00
149,467.00
159,177.00
Liabilities & Shareholders' Equity
148,710.00
201,476.00
261,717.00
194,122.00
225,544.00

About Sirtex Medical

View Profile
Address
101 Miller Street
North Sydney New South Wales (NSW) 2060
Australia
Employees -
Website http://www.sirtex.com
Updated 09/14/2018
Sirtex Medical Ltd. engages in the research, commercial development, manufacture, and distribution of liver cancer treatments. It offers targeted radiation therapy known as SIR-Spheres Y-90 resin microspheres. Its clinical programs include SIRFLOX, FOXFIRE/FOXFIRE Global, SARAH, SIRveNIB, and SORAMIC.